{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:30Z","timestamp":1791910350771,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101055152"],"award-info":[{"award-number":["101055152"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["0153\\u201300238B"],"award-info":[{"award-number":["0153\\u201300238B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008733","name":"Erik H\u00f8rslev and Birgit H\u00f8rslev Fund","doi-asserted-by":"publisher","award":["legat 2024"],"award-info":[{"award-number":["legat 2024"]}],"id":[{"id":"10.13039\/100008733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20OC0062899"],"award-info":[{"award-number":["NNF20OC0062899"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118280","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:51:12Z","timestamp":1784789472000},"page":"118280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models"],"prefix":"10.1016","volume":"253","author":[{"given":"Dagmar F\u00e6ster","family":"Kildedal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid Norup","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Kledal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads G.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-3254","authenticated-orcid":false,"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Drzazga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118280_b0005","series-title":"Chemokines and Viral Infection","first-page":"121","article-title":"A Viral Conspiracy: Hijacking the Chemokine System Through Virally Encoded Pirated Chemokine Receptors","author":"Vischer","year":"2006"},{"key":"10.1016\/j.bcp.2026.118280_b0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-virology-100220-113942","article-title":"Viral G Protein\u2013Coupled Receptors Encoded by \u03b2- and \u03b3-Herpesviruses","volume":"9","author":"Rosenkilde","year":"2022","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/pharmrev.120.000186","article-title":"Viral G protein\u2013coupled receptors: Attractive targets for herpesvirus-associated diseases","volume":"73","author":"De Groof","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118280_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118280_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bph.17379","article-title":"Insight into structural properties of viral G protein-coupled receptors and their role in the viral infection: IUPHAR Review 41","volume":"182","author":"Tsutsumi","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118280_b0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0463.2004.apm11207-0808.x","article-title":"The chemokine system \u2013 a major regulator of angiogenesis in health and disease","volume":"112","author":"Rosenkilde","year":"2004","journal-title":"APMIS"},{"issue":"6614","key":"10.1016\/j.bcp.2026.118280_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/385347a0","article-title":"Human herpesvirus KSHV encodes a constitutively active G-protein- coupled receptor linked to cell proliferation","volume":"385","author":"Arvanitakis","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118280_b0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1074\/jbc.274.2.956","article-title":"Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74","volume":"274","author":"Rosenkilde","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118280_b0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/mol.57.3.602","article-title":"Potency of Ligands Correlates with Affinity measured against Agonist and Inverse Agonists but not against Neutral Ligand in Constitutively active Chemokine Receptor","volume":"57","author":"Rosenkilde","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118280_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(98)01551-8","article-title":"Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28","volume":"441","author":"Kledal","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2026.118280_b0055","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1074\/jbc.M407536200","article-title":"CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor","volume":"280","author":"Casarosa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118280_b0060","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.277.5332.1656","article-title":"A broad-spectrum chemokine antagonist encoded by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"277","author":"Kledal","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118280_b0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1083\/jcb.200712066","article-title":"Activation of G\u03b1i3 triggers cell migration via regulation of GIV","volume":"182","author":"Ghosh","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118280_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abl4283","article-title":"Migration mediated by the oxysterol receptor GPR183 depends on arrestin coupling but not receptor internalization","volume":"16","author":"Kj\u00e6r","year":"2023","journal-title":"Sci. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2026.118280_b0075","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1073\/pnas.112198299","article-title":"Defective lymphocyte chemotaxis in-arrestin2-and GRK6-deficient mice","volume":"99","author":"Fong","year":"2002","journal-title":"Proc. Natl Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2026.118280_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1600-0854.2003.00079.x","article-title":"Endocytosis of the viral chemokine receptor US28 does not require beta-arrestins but is dependent on the clathrin-mediated pathway","volume":"4","author":"Fraile-Ramos","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.bcp.2026.118280_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124486","article-title":"The viral G protein-coupled receptor ORF74 hijacks \u03b2-arrestins for endocytic trafficking in response to human chemokines","volume":"10","author":"De Munnik","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118280_b0090","doi-asserted-by":"crossref","unstructured":"J.B. Park, B. Sahoo, A.R. Sahoo, D. Kim, H.D. Seo, J. Bowman, M.J. Kwak, S. Suh, M. Buck, X. Dai, J.U. Jung, Structural basis for ligand promiscuity and high signaling activity of Kaposi\u2019s Sarcoma-associated Herpesvirus-encoded GPCR, Nat. Commun. 2025 16:1 16 (2025) 1\u201318. https:\/\/doi.org\/10.1038\/s41467-025-63457-4.","DOI":"10.1038\/s41467-025-63457-4"},{"key":"10.1016\/j.bcp.2026.118280_b0095","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.bcp.2026.118280_b0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2023.1135280","article-title":"Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges","volume":"14","author":"Berg","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118280_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejmech.2018.05.053","article-title":"Ligand-selective small molecule modulators of the constitutively active vGPCR US28","volume":"155","author":"Am\u0103randi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118280_b0110","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1128\/JVI.76.4.1744-1752.2002","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44\/p42 MAPK and Akt via Gi and phospholipase C-dependent signaling pathways","volume":"76","author":"Smit","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cbdd.12848","article-title":"Structure-based discovery of novel US28 small molecule ligands with different modes of action","volume":"89","author":"L\u00fcckmann","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bcp.2026.118280_b0120","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1038\/s41467-021-24574-y","article-title":"Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies","volume":"12","author":"De Groof","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118280_b0125","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1021\/acs.molpharmaceut.9b00360","article-title":"Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells","volume":"16","author":"De Groof","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2026.118280_b0130","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1038\/s41467-021-24608-5","article-title":"Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies","volume":"12","author":"De Groof","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118280_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4069260","article-title":"Novel Chemokine-based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells","volume":"2017","author":"Spiess","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bcp.2026.118280_b0140","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.1509392112","article-title":"Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo","volume":"112","author":"Spiess","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2026.118280_b0145","doi-asserted-by":"crossref","first-page":"14321","DOI":"10.1038\/ncomms14321","article-title":"Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein","volume":"8","author":"Krishna","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118280_b0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.healun.2021.10.010","article-title":"Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin","volume":"41","author":"Ribeiro","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bcp.2026.118280_b0155","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.healun.2020.01.1310","article-title":"Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion","volume":"39","author":"Vp Ribeiro","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.bcp.2026.118280_b0160","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.ajt.2026.02.005","article-title":"Inhibition of cytomegalovirus reactivation by ex vivo treatment of human kidneys with the SYN002 immunotoxin","volume":"26","author":"Poole","year":"2026","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118280_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118797","article-title":"Targeting of Kaposi\u2019s sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74","volume":"195","author":"Kildedal","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118280_b0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/34193","article-title":"G-protein-coupled receptor of Kaposi\u2019s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator","volume":"391","author":"Bais","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118280_b0175","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI4461","article-title":"Chemokines activate Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture","volume":"102","author":"Gershengorn","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118280_b0180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1006\/bbrc.1998.9557","article-title":"Kaposi\u2019s Sarcoma-Associated Herpesvirus (KSHV) Chemokine vMIP-II and Human SDF-1<alpha> Inhibit Signaling by KSHV G Protein-coupled Receptor","volume":"253","author":"Geras-Raaka","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118280_b0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.virol.2004.04.027","article-title":"Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74","volume":"325","author":"McLean","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2026.118280_b0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-virology-011921-082615","article-title":"Conquering the host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68","volume":"8","author":"Wang","year":"2021","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0195","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/0022-1317-82-5-1187","article-title":"Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor","volume":"82","author":"Wakeling","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0200","doi-asserted-by":"crossref","unstructured":"4th H W Virgin, P. Latreille, P. Wamsley, K. Hallsworth, K.E. Weck, A.J.D. Canto, S.H. Speck, Complete sequence and genomic analysis of murine gammaherpesvirus 68, J. Virol. 71 (1997) 5894, https:\/\/doi.org\/10.1128\/JVI.71.8.5894-5904.1997.","DOI":"10.1128\/jvi.71.8.5894-5904.1997"},{"key":"10.1016\/j.bcp.2026.118280_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008192","article-title":"A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency","volume":"15","author":"L\u00f3pez-Rodr\u00edguez","year":"2019","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bcp.2026.118280_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0042-6822(02)00023-5","article-title":"Disruption of the gene encoding the HV68 v-GPCR leads to decreased efficiency of reactivation from latency","volume":"307","author":"Moorman","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2026.118280_b0215","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/JVI.78.7.3343-3351.2004","article-title":"Differential activation of murine herpesvirus 68- and Kaposi\u2019s sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines","volume":"78","author":"Verzijl","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0220","series-title":"Targeting Trafficking in Drug Development","first-page":"41","article-title":"Investigating internalization and intracellular trafficking of GPCRs: new techniques and real-time experimental approaches","author":"Foster","year":"2017"},{"key":"10.1016\/j.bcp.2026.118280_b0225","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fmicb.2015.00963","article-title":"Pseudomonas Exotoxin a: optimized by evolution for effective killing","volume":"6","author":"Michalska","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2026.118280_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"[19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods in Neurosciences"},{"issue":"6","key":"10.1016\/j.bcp.2026.118280_b0235","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1189\/jlb.2MR1015-468R","article-title":"The future of antiviral immunotoxins","volume":"99","author":"Spiess","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118280_b0240","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.cmi.2025.04.046","article-title":"Herpes simplex virus and drug resistance\u2014comprehensive update on resistance mutations and implications for clinical management: a narrative review","volume":"31","author":"D\u00e4hne","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bcp.2026.118280_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0250","doi-asserted-by":"crossref","first-page":"45979","DOI":"10.1074\/jbc.M104783200","article-title":"Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi\u2019s sarcoma-associated herpesvirus involve G alpha(13) and RhoA","volume":"276","author":"Shepard","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118280_b0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","article-title":"Kaposi\u2019s Sarcoma-Associated Herpesvirus G Protein-coupled Receptor Constitutively Activates NF-\u03baB and Induces Proinflammatory Cytokine and Chemokine Production Via a C-Terminal Signaling Determinant","volume":"167","author":"Schwarz","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118280_b0260","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1172\/JCI13622","article-title":"Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity","volume":"108","author":"Holst","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2026.118280_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2004.09.017","article-title":"Virus-encoded chemokine receptors - Putative novel antiviral drug targets","volume":"48","author":"Rosenkilde","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.118280_b0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/mol.105.011239","article-title":"High Constitutive activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY motif (Asp-Arg-Tyr) in Transmembrane Helix 3","volume":"68","author":"Rosenkilde","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118280_b0275","doi-asserted-by":"crossref","unstructured":"M.M. Rosenkilde, K.A. Mclean, P.J. Holst, T.W. Schwartz, The CXC Chemokine Receptor Encoded by Herpesvirus saimiri, ECRF3, Shows Ligand-regulated Signaling through G i , G q , and G 12\/13 Proteins but Constitutive Signaling Only through G i and G 12\/13 Proteins*, J. Biol. Chem. 279(31) (2004) 32524-32533. https:\/\/doi.org\/10.1074\/jbc.M313392200.","DOI":"10.1074\/jbc.M313392200"},{"key":"10.1016\/j.bcp.2026.118280_b0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2004.07.076","article-title":"HCMV-encoded chemokine receptor US28 employs multiple routes for internalization","volume":"322","author":"Droese","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118280_b0285","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/JVI.79.1.536-546.2005","article-title":"Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor","volume":"79","author":"Paulsen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118280_b0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s11658-023-00427-y","article-title":"Open Access patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis","volume":"28","author":"Mavri","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bcp.2026.118280_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02070-9","article-title":"Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization","volume":"4","author":"J\u00f8rgensen","year":"2021","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118280_b0300","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/cells10030618","article-title":"Differential Involvement of ACKR3 C-Tail in \u03b2-Arrestin Recruitment, Trafficking and Internalization","volume":"10","author":"Zarca","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2026.118280_b0305","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/1061186X.2021.1894435","article-title":"Immunotoxins and nanobody-based immunotoxins: review and update","volume":"29","author":"Khirehgesh","year":"2021","journal-title":"J. Drug Target"},{"key":"10.1016\/j.bcp.2026.118280_b0310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/toxins17090459","article-title":"Bacterial Protein Toxins as Anticancer Agents: Clinical potential of Pseudomonas and Anthrax Toxins","volume":"17","author":"Misra","year":"2025","journal-title":"Toxins (Basel)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:22:52Z","timestamp":1791908572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":62,"alternative-id":["S0006295226006192"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118280","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118280"}}